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Abstract
Low-grade cribriform cystadenocarcinoma (LGCCA) is a rare tumor of the salivary gland that exhibits clinically
indolent behavior. In this paper, we present a case of invasive adenocarcinoma of the accessory parotid gland in a
young male that exhibited histology suggestive of an association of LGCCA. A 27-year-old man presented with a
subcutaneous tumor in his left cheek. The tumor was separated from the parotid gland and located on the
masseter muscle. The tumor was resected, and the postoperative histological diagnosis was adenocarcinoma, not
otherwise specified (ANOS). The tumor exhibited papillary-cystic and cribriform proliferation of the duct epithelium
and obvious stromal infiltration. Some tumor nests were rimmed by myoepithelium positive for smooth muscle
actin, p63, and cytokeratin 14, indicating the presence of intraductal components of the tumor. Tumor cells
exhibited mild nuclear atypia, and some of them presented an apocrine-like appearance and had cytoplasmic PAS-
positive/diastase-resistant granules and hemosiderin. Other cells had foamy cytoplasm with microvacuoles.
Immunohistochemistry revealed that the almost all of the tumor cells were strongly positive for S-100. These
histological findings suggest the possibility that ANOS might arise secondarily from LGCCA. This is an interesting
case regarding the association between ANOS and LGCCA in oncogenesis.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1226764594634693.
Keywords: accessory parotid gland, low-grade cribriform cystadenocarcinoma, adenocarcinoma, not otherwise spe-
cified, salivary duct carcinoma, S-100
Background
Delgado et al originally described low-grade cribriform
cystadenocarcinoma (LGCCA) as a rare low-grade var-
iant of salivary duct carcinoma (SDC) in 1996 [1]. This
tumor predominantly consists of intraductal compo-
nents of the tumor and frequently exhibits papillary-cys-
tic or cribriform proliferation similar to a low-grade
ductal carcinoma in situ or atypical ductal hyperplasia
of the breast in its histology and biologically indolent
features [1-9]. This low-grade variant of SDC makes a
contrast with conventional SDC, which is a clinically
aggressive tumor that exhibits high-grade histology
similar to an invasive ductal carcinoma of the breast
[10,11]. Evidence for distinct relationships between these
2 entities has not been demonstrated; therefore, this
low-grade variant of SDC is categorized as a variant of
cystadenocarcinoma, termed LGCCA, in the World
Health Organization classification (2005) due to its cys-
tic morphology [2]. Past literatures have described rare
cases with LGCCA that subsequently exhibited overt
invasive growth in their clinical courses [6]. Herein, we
present a case of invasive adenocarcinoma of the acces-
sory parotid gland in a young male that had left vestiges
of LGCCA in its histology. The invasive component of
the tumor was histologically defined as adenocarcinoma,
not otherwise specified (ANOS). This is an interesting
case suggests that ANOS could secondarily arise from
LGCCA of the salivary gland.
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Clinical summary
A 27-year-old man with more than 1-year history of a sub-
cutaneous tumor in his left cheek consulted the Depart-
ment of Plastic Reconstructive Surgery at our hospital.
His past medical history and family history were unre-
markable. Physical examination revealed an elastic hard
tumor in the subcutis of his left cheek. The tumor did not
adhere to the skin. There was no remarkable abnormality
in his oral and nasal cavities. No lymph node swelling was
observed in his head and neck. The patient exhibited no
neurological deficits. Laboratory data were within normal
limits. Magnetic resonance imaging (MRI) revealed a
tumor 15 mm × 7 mm in diameter located anterior to the
left masseter muscle, with lower intensity than the muscle
on both T1- and T2-weighted images (Figure 1a). Imaging
with a fat-suppression technique revealed slightly higher
intensity in the tumor (Figure 1b). MRI findings were
s u g g e s t i v eo fag r a n u l o m ao raf i b r o m a .T h ep a t i e n t
underwent local excision of the tumor under regional
anesthesia. Grossly a whitish tumor was encapsulated by
thin fibrous tissue, and it adhered to the masseter muscle.
Postoperative investigation using MRI and positron emis-
sion tomography revealed no residual tumor or lymph
node metastasis. The final histological diagnosis was
ANOS of the accessory parotid gland. As the tumor was
close to the surgical margin, we recommended that the
patient receives adjuvant radiotherapy, but he did not wish
to undergo the therapy. He is alive without recurrence of
the disease 3 months after the surgery.
Histological findings
The tumor was encapsulated by fibrous tissue but extra-
capsular invasion was partially observed. Normal salivary
gland tissue was observed adjacent to the capsule of the
tumor. It was considered an accessory parotid gland.
Approximately half of the tumor consisted of irregular-
shaped cystic spaces of variable size containing exudates
and hemorrhage (Figure 2a). Colloid-like material such
as that observed in acinic cell carcinoma was not seen.
The epithelial cells lining the cyst exhibited marked
papillary proliferation with a partial cribriform structure
(Figure 2b). The cribriform structure included true
lumens but not pseudo-lumens. Thickened basement
membranes were observed around the tumor cell nests
in the periodic acid-Schiff (PAS) reaction (Figure 2c).
Most tumor cells had a small, round, bland nucleus
with inconspicuous small nucleoli and eosinophilic
cuboidal cytoplasm. An apocrine-like appearance with
apical snouts was observed in some cells (Figure 2d).
Apocrine-like cells had cytoplasmic PAS-positive/dia-
stase-resistant eosinophilic granules (Figure 2e). In the
vicinity of hemorrhage, tumor cells phagocytosed the
brownish pigment, hemosiderin (Figure 2f). Some tumor
cells had foamy cytoplasm with microvacuoles similar to
those of sebaceous cells (Figure 2g). These histological
features were suggestive of LGCCA, but, in the latter
half of the tumor, neoplastic epithelial cords and tubules
considerably infiltrated the parenchyma with myxoid
stromal reactions and sclerosis (Figure 2h). This invasive
component lacked specific histological features of any
other salivary carcinoma; therefore, the final diagnosis of
ANOS was made. Neither intravascular infiltration nor
perineural infiltration was observed.
In immunohistochemistry, some of the papillary-cystic
structures exhibited rimming of the myoepithelium that
was positive for smooth muscle actin (SMA), p63
(Figure 3a), and cytokeratin (CK) 14 (Figure 3b), indicating
Figure 1 Magnetic resonance imaging of the tumor. The tumor is located on the left masseter muscle (arrows). a. Horizontal plane. The
tumor exhibits hypointensity on T1-weighted images. b. Coronal plane. The tumor exhibits slightly higher intensity in T2-weighted imaging with
a fat-suppression technique.
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cells exhibited strong positivity for CK (AE1/AE3), CK 7
and S-100 (Figure 3c), which was compatible with
LGCCA. Epithelial membrane antigen was partially posi-
tive. Glial fibrillary acidic protein was faintly positive in
the cytoplasm. Carcinoembryonic antigen was positive in
the lumen of cystic spaces and tubules (Figure 3d). CK 20,
gross cystic disease fluid protein (GCDFP)-15, CD34
(Figure 3e), and p53 were negative. SMA, p63, and CK 14
were negative in the neoplastic cells other than the myoe-
pithelium rimming the cell nest. As neuroendocrine mar-
kers, synaptophysin was negative (Figure 3f) and a small
Figure 2 Histological findings of the tumor. a. The tumor was encapsulated but extracapsular invasion was partially observed. Papillary-cystic
proliferation was observed within the tumor. Hematoxylin eosin (HE) stain, loupe. b. The tumor cells exhibit markedly papillary proliferation with
a cribriform pattern. Comedonecrosis is not observed. HE stain, original magnification ×100. c. Thickened basement membranes were observed
around the tumor cell nest. PAS reaction, ×400. d. Cuboidal tumor cells lining cystic spaces have eosinophilic cytoplasm and exhibit an apocrine-
like appearance with decapitation. HE stain, ×400. e. Apocrine-like tumor cells have cytoplasmic PAS-positive/diastase-resistant granules. PAS
reaction with diastase digestion, ×400. f. The tumor cells phagocytose hemosiderin in the vicinity of hemorrhage. HE stain, ×400. g. Some tumor
cells have foamy cytoplasm similar to sebaceous cells. HE stain, ×400. h. Cords and tubules of the tumor infiltrate the stroma with sclerosis. HE
stain, ×200.
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Intracytoplasmic granules exhibited faintly non-specific
staining with chromogranin A. The Ki-67 labeling index
was approximately 5% (Figure 3h).
Conclusions
The tumor of the present case was grossly separated
from the parotid gland. As the tumor was located on
the masseter muscle and a histologically normal salivary
gland was observed in the periphery of the tumor, the
tumor might have developed from the accessory parotid
gland. An accessory salivary gland is occasionally
observed on the masseter muscle along with Stensen’s
duct. Neoplasms arising from an accessory parotid gland
are relatively rare, and variable types of malignant
tumor have been reported in the literature: carcinoma
Figure 3 Immunohistochemical findings of the tumor. a and b. Myoepithelium rimming papillary-cystic structure of the tumor is positive for
p63 (a) and cytokeratin 14 (b). Original magnification ×200. c. The tumor cells exhibit strong positivity for S-100. ×200. d. Carcinoembryonic
antigen is positive in the lumen of cystic spaces and tubules. ×200. e. and f. The tumor cells did not exhibit positivity for neither CD34 (e) nor
synaptophysin (f). ×200. g. CD56-positive cells were scattered. ×200. h. The Ki-67 labeling index was approximately 5%. ×200.
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[13], mucoepidermoid carcinoma [14], acinic cell carci-
noma [15], oncocytic carcinoma [16], basal cell carci-
noma [14], and small cell carcinoma [14].
The tumor of the present case included a component
exhibiting papillary-cystic proliferation and another
component with obvious invasion to the parenchyma
with a tubular or scirrhous pattern. Since the invasive
component of the tumor did not exhibit specific histolo-
gical features of any other defined carcinoma, we made
the diagnosis of ANOS. There was myoepithelial rim-
ming of the tumor cell nest with positivity for SMA,
p63, and CK14 in some areas within the tumor, indicat-
ing intraductal proliferation of the duct epithelium.
Additionally, the PAS reaction clearly revealed thickened
basement membranes around the tumor cell nests.
These findings allowed the presumption that the present
tumor might have developed in the precedent intraduc-
tal tumor. In addition, the tumor cells presented an
apocrine-like appearance and included PAS-positive/dia-
stase-resistant granules and hemosiderin in the cyto-
plasm, in line with findings frequently observed in
LGCCA [1-9]. Strong positivity of S-100 in immunohis-
tochemistry in almost all tumor cells was also character-
istic of LGCCA. The aforementioned histological
findings indicated the presence of histological vestiges of
LGCCA in this tumor, suggesting the possibility that
ANOS in this case might have arise secondarily from
the tumor initially developing as LGCCA in the salivary
gland. In principle, LGCCA has good clinical behavior
and exhibits neither recurrence nor metastasis [1-9],
although Weinreb et al reported a rare case of a low-
grade intraductal carcinoma of the parotid gland that
subsequently progressed to adenosquamous carcinoma
[6]. Ihrler et al revealed that an intraductal component
was identified in 15 of 22 patients (68%) with ANOS
and speculated that the intraductal tumor is identified
as the preinvasive precursor of ANOS [17]. Although
there has never been a description of the association
between ANOS and LGCCA, the present case suggested
the possibility that a certain group of ANOS could
develop secondarily from LGCCA. To verify this specu-
lation, accumulation of the evidence about ANOS and
LGCCA using molecular biology techniques will be
required hereafter.
One of the most important differential diagnoses of
the present case is a papillary cystic variant of acinic cell
carcinoma (PCV-ACC). PCV-ACC preferentially affects
young people [18]. Tumor cells of PCV-ACC have intra-
cytoplasmic PAS-positive/diastase-resistant granules
(zymogen) and hemosiderin, as observed in LGCCA
[18]. However, PCV-ACC is typically negative for S-100
and typically does not exhibit predominance of the
intraductal component of the tumor in histology.
Sebaceous cell-like foamy cells with microvacuoles are
sometimes seen in cystadenocarcinoma of the salivary
gland. Intracytoplasmic vacuoles are found also in PCV-
ACC, but uniformly-sized, fine microvacuoles might be
considered characteristic of cystadenocarcinomas,
including LGCCA, rather than PCV-ACC [19]. Another
differential diagnosis is SDC. SDC is a high-grade ade-
nocarcinoma that is common in elderly people over 50
years of age [10,11]. Histologically, SDC resembles a
high-grade invasive ductal carcinoma of the breast, fre-
quently accompanied by comedonecrosis and cribriform
proliferation [10,11]. SDC exhibits an apocrine-like
appearance with positivity for GCDFP-15 and androgen
receptor, which is occasionally observed in LGCCA, but
SDC is negative for S-100. SDC usually exhibits a high
Ki-67 labeling index, whereas the index in our case was
low (approximately 5%). Pleomorphic adenoma and car-
cinoma ex pleomorphic adenoma should be listed as a
differential diagnosis [20], although the tumor of our
case did not include a component showing typical his-
tology of pleomorphic adenoma, such as transition from
myoepithelium to stromal spindle cell and myxoid or
cartilaginous stroma. Neuroendocrine tumors were
excluded because rosette-like or trabecular configuration
was not observed and almost all tumor cells did not
express neuroendocrine markers except for scattered
CD56-positive cells.
We presented a case of ANOS developing in the
accessory salivary gland that suggests an association
with LGCCA. This is an interesting case when consider-
ing the relationship between ANOS and LGCCA in
oncogenesis. This case is meaningful in reconsidering
the disease entity and the process of development of
ANOS of the salivary gland.
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